| Alfalfa meal | Rats | Alfalfa meal (5%, 12.5%, 20%) + T-2 (3 μg/g feed) for 2 weeks. | Gastrointestinal toxicity | - Antagonizing food refusal and growth inhibition toxicity in rats. | - Binding T-2 in gastrointestinal tract and thus promoting fecal excretion. | Carson and Smith (1983a) |
| RA | IPEC-J2 cells | Pre-incubated with RA (50 μmol/L) for 24 h; T-2 (5 nmol/L) for 48 and 72 h. | - Alleviating intestinal cell damage. | - Antioxidant; - Anti-inflammation. | Pomothy et al. (2020a) |
| BA | Mice | Pretreated with BA (0.25, 0.5, 1 mg/kg BW i.g.) for 2 weeks; T-2 (4 mg/kg BW i.p.) once. | - Improving the antioxidant capacity and the intestinal inflammatory response of the intestine; - Alleviating intestinal immune barrier dysregulation. | - Antioxidant; - Anti-inflammation. | Luo et al. (2020) |
| FWGE | IPEC-J2 cells | FWGE (1% and 2%) + T-2 (5 nmol/L) for 24 h. | - Improving cell viability and cell monolayer integrity. | - Antioxidant. | Pomothy et al. (2020b) |
| Bentonite | Rats | Pretreated with bentonite (5%, 7.5% or 10%) for 2 weeks; T-2 (3 μg/g feed) once. | - Overcoming the toxic symptoms of growth inhibition and food refusal in rats. | - Shortening the transit time of T-2 in the intestine. | Carson and Smith (1983b) |
| Smectite | Mice | T-2 was incubated with smectite for 24 h before oral administration; T-2 (1 mg/kg BW/d, p.o.); Smectite (2 g/kg/d). | - Protecting mice against T-2-induced disturbances of gastrointestinal transit. | - Smectite reinforced the natural defense of the gastric mucosa. | Fioramonti et al. (1987) |
| Mineral clays | Caco-2 cells | T-2 (100 μmol/L) + 0.1 mg/mL of each clay (diosmectite, montmorillonite, and illite) for 24 h. | - Restoring intestinal barrier permeability. | - Reversing T-2-induced reduction in the tight junction constituents claudin-3, claudin-4 and occludin expression and trans-epithelial electrical resistance. | Romero et al. (2016) |
| HSCAS | Broilers | 0.05% HSCAS + T-2 (6.0 mg/kg feed) for 2 weeks. | - Reducing the toxicity of T-2 in broilers. | - Reducing T-2-induced toxicity in growth performance, nutrient digestibility, and small intestinal morphology. | Wei et al. (2019) |
| MycoRaid | Broilers | MycoRaid (1 or 3 g/kg feed) + T-2 (1 mg/kg feed) for 1–10 d. | - Improving broilers performance. | - Restoring feed consumption and body weight; - Increasing the concentration of total protein and albumin in the blood. | Riahi et al. (2021) |
| SeMet | Rabbits | Orally administered with SeMet (0.2, 0.4 and 0.6 mg/kg feed) for 21 d; On 17th d, each group began to take 0.4 mg/kg feed of T-2 orally/d for 5 d. | - Protecting the intestine from damage caused by T-2. | - Alleviating oxidative stress, jejunal inflammation; - Preserving the integrity of the intestinal barrier. | Liu et al. (2020) |
| FPH | Human colon cancer TC7 cells and Caco-2. | FPH (0.0625 mg/mL) + T-2 (60 nmol/L) for 24 h. | - Protecting against T-2-induced cytotoxicity. | - Improving cell viability. | Taroncher et al. (2021) |
| Prednisolone and hydrocortisone | Mice | Pretreated i.p. with 100 mg/kg BW of prednisolone or hydrocortisone for 3 d; T-2 (1.8 mg/kg BW, s.c.) for 4 d. | - Suppressing the lethal toxicity. | - Anti-inflammation. | Mutoh et al. (1988) |
| Dietary nucleotides | Male broiler chickens | Exposed T-2 (10 mg/kg feed) with nucleotides (2 g/kg feed) for 17 d. | Immunotoxicity | - Having beneficial effect on the immune system in T-2 intoxication. | - Reducing T-2-induced DNA fragmentation in spleen leukocytes. | Frankic et al. (2006) |
| Se | Mice | The sublethal dose of T-2. | - Asserting an important effect against the immunotoxic effects of T-2. | - Suppressing the T-2-induced reduction in peripheral blood B lymphocytes (CD19+) abundance. | Ahmadi et al. (2015) |
| SeMet | Rabbits | Orally administered with SeMet (0.2, 0.4 and 0.6 mg/kg feed) for 21 d. On 17th d, each group began to take 0.4 mg/kg BW of T-2 orally every day for 5 d. | - Attenuating T-2-induced immunotoxicity. | - Improving its antioxidant and anti-inflammatory capabilities in the spleen and thymus. | Zhang et al. (2022h) |
| Arginine | Chinese mitten crab | Pretreated with 3.17% arginine for 8 weeks; Injected with T-2 (1.5 mg/kg BW). | - Resistance to T-2-induced immune damage in the hepatopancreas. | - Increasing the antioxidant capacity. | Zhang et al. (2020a) |
| BA | Mice | Pretreated with BA (0.25, 0.5, or 1 mg/kg BW i.g.) for 2 weeks, T-2 (4 mg/kg BW single i.p.). | - Exerting the antioxidative and immunomodulatory activities of BA on spleen oxidative damage induced by T-2. | - Elevating the activities of antioxidant enzymes, reducing lipid peroxidation and ROS accumulation, and decreasing splenocyte apoptosis. | Kong et al. (2021) |
| - Protecting the thymus against the oxidative damage challenged by T-2. | - Activating Nrf2 and suppressing the MAPK signaling pathway. | Zhu et al. (2020) |
| NAC | Neuroblastoma- 2a cells | Pretreated with NAC (5 mmol/L) for 2 h, followed by treatment with T-2 (20 ng/mL) for 24 h. | Neurotoxicity | - Reducing neurotoxicity. | - Inhibiting caspase activation and apoptosis. | Zhang et al. (2018) |
| Mouse microglia BV2 cell line. | Pretreated with NAC at 2.5 mmol/L for 1 h, followed by co-treatment with T-2 at 2.5 ng/mL for additional 24 h. | - Reducing oxidative stress and apoptosis. | - Preventing ROS production and mitochondrial dysfunction; - Reducing mitochondrial transmembrane potential. | Sun et al. (2022) |
| BA | Mice | Pretreated with BA (0.25, 0.5, and 1.00 mg/kg BW) for 14 d; T-2 (4 mg/kg BW, single i.p.). | - Protecting against brain damage induced by T-2. | - Increasing the levels of the brain neurotransmitters dopamine, 5-hydroxytryptamine, and acetylcholine, thus improving cognitive function. - Enhanced antioxidant and anti-inflammatory capacity in the brain. | Huang et al. (2022b) |
| Minocycline | Mice | Injected with T-2 (4 mg/kg BW) + minocycline (50 mg/kg BW). | - Suppressing the neurotoxicity caused by T-2. | - Inhibiting microglia activation, thus improving T-2-induced learning and memory impairment and locomotor inhibition. | Li et al. (2023) |
| L-arginine | Mouse Leydig cells | Treated with T-2 (10 nmol/L) + L-arginine (0.25, 0.5, or 1.0 mmol/L) for 24 h. | Reproductive toxicity | - Ameliorating T-2–induced cytotoxicities. | - Elevating antioxidative ability. | Yang et al. (2018) |
| - Ameliorated the testosterone levels decreased by T-2. | - Regulating the mRNA expression and activities of StAR. | Yang et al. (2019b) |
| - Blocking T-2-induced apoptosis | - Regulating specific intracellular death-related pathways. | Zhang et al. (2020b) |
| Mice | Pretreated with L-arginine (5, 15, 25 g/kg feed) for 7 d; T-2 (10 mg/kg BW/d i.p.) for 7 d. | - Protecting reproductive impairments induced with T-2. | - Improving semen quality and serum testosterone levels. | Zhang et al. (2019) |
| Melatonin | Bovine ovarian granulosa cells | -Pretreated with melatonin (100 μmol/L) for 12 h; HT-2 toxin 50 nmol/L for 24 h. | - Alleviating HT-2 toxin-induced cells damage. | - Having protective effects against mycotoxin-induced apoptosis and oxidative stress. | Yang et al. (2019a) |
| Quercetin | Porcine ovarian granulosa cells | Quercetin (100 ng/mL) + T-2 (100 ng/mL) for 24 h. | - Mitigating cellular oxidative damage due to T-2 exposure. | - Increasing the antioxidant capacity. | Capcarova et al. (2015) |
| BA | Mice | Pretreated orally with BA (0.25, 0.5, and 1.0 mg/kg feed/d) for 14 d, T-2 (4 mg/kg BW i.p.) once. | - Having protective effect of BA on T-2-induced testicular injury. | - Reducing the oxidative damage by the JAK2/STAT3 pathway. | Wu et al. (2019) |
| NAC | TM4 cells (The Sertoli cell line) | T-2 (4 nmol/L) + NAC (5 mmol/L) for 24 h. | - Relieving TM4 cell functional injury. | - Inhibiting low cell viability, oxidative stress and cell apoptosis caused by T-2. | Yang et al. (2021) |
| VE and Se | Bovine Leydig cells | 100 nmol/L Se+10 nmol/L T-2; 100 μmol/L VE+10 nmol/L T-2; 100 nmol/L Se+100 μmol/L VE+10 nmol/L T-2 for 24 h. | - Ameliorating T-2-induced cytotoxicities. | - Preventing oxidative stress and DNA damage. | Yang et al. (2022) |
| Se | Rats | Pre-supplementation Se (0.5 and 2.5 mg/kg feed for 6 weeks); T-2 (3.8 mg/kg BW). | Hepatotoxicity | - Reducing mortality due to T-2. | - Se affected liver metabolism. | Kravchenko et al. (1990) |
| Se, VE, VC | Rats | Received Se (0.15 mg), VE (15 mg) and VC (6 mg) i.g. 16 h before the administration of T-2 (3.6 mg/kg BW orally a single dose). | - Alleviating liver injury. | - Reducing T-2-induced hepatic LPO and GSH depletion. | Rizzo et al. (1994) |
| Modified glucomannans and organic Se | Chicken | Mycosorb (1 g/kg feed) Sel-Plex (Se 0.3 mg/kg feed); T-2 (8.1 mg/kg feed for 21 d). | - Preventing T-2-induced oxidative stress damage and LPO in liver. | - Protecting against the detrimental effects of T-2 on the antioxidant defences in the chicken liver. | Dvorska et al. (2007) |
| SeMet | New Zealand rabbits | SeMet (0.2 mg/kg feed) for 21 d. On the 17th day, orally administered with T-2 (0.4 mg/kg BW) for 5 d. | - Improving T-2-induced liver injury. | - Inhibiting the mitochondrial- caspase apoptosis pathway. | Liu et al. (2021c) |
| CoQ10, VE | Mice | Gavage pretreatment with CoQ10 (6 mg/kg BW) and alpha-tocopherol (6 mg/kg BW) for 4 weeks. T-2 (1.8 or 2.8 mg/kg BW, single oral dose). | - Blocking T-2-induced hepatocyte death and GSH depletion. | - Reducting T-2-induced DNA damage in livers. | Atroshi et al. (1997) |
| Lycopene | Broiler chickens | T-2 (1.5 mg/kg BW/d) + Lycopene (25 mg/kg BW/d) for 7, 14 and 21 d. | - Alleviated oxidative damage in the liver of chickens fed T-2. | - Stopping GSH depletion in liver cells. | Leal et al. (1999) |
| Food indoles | Rats | Fed with 0.1% food indoles for 8 d; T-2 (0.8 mg/kg BW). | - Attenuating the hepatotoxicity of T-2. | - Elevating activity of microsomal carboxylesterase and UDP-glucuronosyltransferase, the key enzymes for detoxification of T-2. | Kravchenko et al. (2001) |
| HSCAS | Broilers | 0.05% modified HSCAS adsorbent + T-2 (6.0 mg/kg feed) for 2 weeks. | - Blocking T-2-induced AST elevation and mitigating hepatotoxicity. | - Increasing surface area and might be able to increase adsorbing mycotoxins and avoid adsorbing the nutrients in feed. | Wei et al. (2019) |
| Arginine | Chinese mitten crab | Pretreated with 3.17% Arg for 8 weeks; Injected with T-2 (1.5 mg/kg BW). | - Alleviating T-2-induced hepatotoxicity. | - Enhancing the antioxidant capacity of Chinese mitten crab against oxidative damage to the hepatopancreas induced by T-2. | Zhang et al. (2020a) |
| YCWE and PYCW | Broilers | Contaminated diet containing T-2 (104 g/kg feed) + 0.2% YCWE or 0.2% PYCW. | - Improving the negative effects of T-2 on growth performance and liver function. | | Kudupoje et al. (2022) |
| CC2 | Mice | 20% CC-2 formulation was applied on the exposed dorsal surface at 5, 15, 30 and 60 min after T-2 (11.8 mg/kg BW percutaneous exposure). | - Protecting mice from T-2-induced hepatic LPO; - Reducing mortality. | | Agrawal et al. (2012a) |
| L-Carnitine | Rats, primary rat hepatocytes | Received L-carnitine (50 or 500 mg/kg i.p.) for 5 d, rat hepatocytes were isolated and treated with T-2 (640 ng/mL) for 2 h. | - Alleviating liver injury. | - Antioxidant properties, mitochondrial protection and inhibition of apoptosis. | Moosavi et al. (2016) |
| CA | Broiler chickens | 1% CA-supplemented diet for 4 d; T-2 (2.0 mg/kg BW) oral administration for 4 d. | - Alleviating T-2-induced liver damage and the broiler mortality. | - Inducing the expression of FXR, thus reducing inflammatory and oxidative stress in hepatocytes. | Dai et al. (2020) |
| Curcumin and taurine | Rats | Administrated T-2 sublethal oral dose (0.1 mg/kg BW i.p.) for 2 months, followed by curcumin (80 mg/kg BW) and taurine (50 mg/kg BW) for 3 weeks. | - Ameliorating T-2-induced hepatotoxicity. | - Improving antioxidant capacity. | Al-Zahrani et al. (2023) |
| SeMet | Rabbits | Fed diets containing SeMet (0.2 mg/kg) for 21 d; On the 17th day, perfused with T-2 (0.4 mg/kg BW) for 5 d. | Nephrotoxicity | - Restoring kidney function. | - Reducing T-2-induced ROS and inflammatory factor levels. | Liu et al. (2021b) |
| Se | Mice | Pretreated with Se (0.2 mg/kg BW/d) for 2 h, then exposed to T-2 (1.0 mg/kg BW/d) for 28 d. | - Alleviating T-2-induced nephrotoxicity. | - Inhibiting ROS-mediated renal apoptosis. | Zhang et al. (2022f) |
| BA | Porcine kidney cells | Pretreated with BA (0.25, 0.5, and 1 μmol/L) for 24 h, continued with subsequent T-2 (1 μmol/L) for 24 h. | - Alleviating renal cytotoxicity. | - Ameliorating T-2-induced oxidative stress damage and apoptosis by increasing SOD, GSH-Px, and CAT activity and reducing intracellular ROS and MDA production. | Li et al. (2021) |
| Mice | Pretreated with BA (0.25, 0.5, and 1 mg/kg BW i.g.) for 14 d; T-2 (4 mg/kg BW) was injected intraperitoneally at the 9th h after the last oral administration of BA. | - Protecting against renal damage. | - Attenuating oxidative stress and inflammation via Nrf2 pathway. | Huang et al. (2021) |
| Catalase and VC | Rat cardiomyocytes | T-2 (6.0 × 10−3 and 6.0 × 10−4 μmol/L) + VC (10 μg/mL) or catalase (10 U/mL) for 24 h. | Cardiomyopathy | - Improving the mitochondrial dysfunction under T-2 exposure. | - Antioxidant effects. | Ngampongsa et al. (2013) |
| Se | Primary cardiomyocytes | T-2 (0.25−1 μmol/L) | - Selenium deficiency lowered cytoprotective autophagy in the primary cardiomyocytes treated by T-2. | - The combination effects of selenium deficiency and T-2 on the development of Keshan disease. | Chen et al. (2019) |
| Methylprednisolone | Rats | Methylprednisolone (a total single dose of 40 mg/kg i.m.) was given immediately after T-2 (0.23 mg/kg s.c.). | - Showing a significant cardioprotective efficacy. | - Anti-inflammatory activity. | Jacevic et al. (2019) |
| Se | Chondrocytes | T-2 (0.001–2 mg/L). | Skeletal toxicity | - Partly antagonizing the inhibitory effects of T-2 on aggrecan. | | Chen et al. (2006); Li et al. (2008) |
| - Inhibiting aggrecan degradation in chondrocytes induced by T-2. | |
| An artificial cartilage model | Se (0.1 μg/mL) for 14 d; T-2 (1, 10 and 20 ng/mL). | - Having a protective role on chondrocytes. | - Preventing the decrease in type II collagen protein induced by T-2 in engineered cartilage. | Chen et al. (2011) |
| Cultured chondrocytes | T-2 (5, 10, 20, 40 and 80 ng/mL) supplemented with Na2SeO3 (50, 100 and 150 ng/mL), and incubated for 6, 12, 24, 36 and 48 h. | - Reducing T-2-induced cytotoxicity. | - Promoting metabolic conversion of T-2. | Yu et al. (2017) |
| Rats, primary epiphyseal chondrocytes | Administered with low Se (0.09 ng/g) and/or T-2 (100 ng/g BW per day) for 4 weeks to establish a KBD animal model. | - Inhibiting the progress of KBD. | - Reversing the effects of T-2 on chondrocyte injury. | Shi et al. (2021) |
| Rats | Administered with T-2 (200 ng/g BW per day) for 4 weeks under the Se-deficient diet. | - Se-supplementation partially antagonized the inhibitory effects of T-2 in chondrocytes and cartilages. | - Low selenium induced matrix degradation. | Zhang et al. (2021a) |
| NAC | Chicken tibial growth plate chondrocytes | NAC (0.5 mmol/L) was co-administered with T-2 (5, 50, and 500 nmol/L) for 48 h. | - Protecting chicken growth plate chondrocytes. | - Reducing T-2-induced oxidative stress. | He et al. (2012) |
| Mycotoxin adsorbents: EGM, HSCAS, CMA | Broilers | The mycotoxins-contaminated feed containing T-2 (320.5 μg/kg) + 0.05% EGM or +0.2% HSCAS or + 0.1% CMA for 10, 21, 35 and 42 d. | Muscle toxicity | - Preventing the adverse effects on meat quality of mycotoxins to varying extents. | - Improving growth performance and nutritional retention in broilers due to mycotoxins. | Liu et al. (2011) |
| Quercetin | Shrimps | Quercetin (2.00 to 32.00 g/kg feed) or tea polyphenols or rutin + T-2 (4.80–24.30 mg/kg feed) for 20 d. | - Having the protective effect on T-2-induced muscle toxicity. | - Preventing abnormal changes in the target protein and muscle composition; - Reducing the degree of muscle protein deterioration. | Huang et al. (2022a) |
| Tea polyphenols and rutin | - Ameliorating the T-2-induced damage to muscle proteins. | - Increasing the sarcoplasmic and myofibrillar protein content and decreasing the alkali-soluble protein content. |
| Menthol | Mice | T-2 (2.97 mg/kg BW) for 72 h and 120 h; 0.25% and 0.5% menthol. | Skin toxicity | - Having the protective effect against T-2- induced skin toxicity in mice. | - Anti-inflammatory effect. | Rachitha et al. (2023) |
| CC-2 | Mice | The subcutaneous application of 20% CC-2 within 5 and 15 min of treatment with T-2 (23.76 mg/kg BW topical percutaneous smearing). | - CC-2 may be an effective skin decontaminant against lethal topical exposure to T-2. | | Agrawal et al. (2012a) |
| Quince seed | Rabbits | 100 μg T-2 was dissolved in 12 μL methanol and applied on the shaved skin of rabbit for 2 d. Quince seed mucilage (15%). | - Showing more and better healing effects on dermal toxicity caused by T-2. | | Hemmati et al. (2012) |